Navigation Links
InspireMD Appoints Robert Ratini as Vice President of Sales and Marketing
Date:4/9/2012

n the stent market.  We look forward to the strategic contributions and the fresh insights Robert will bring during this exciting time for InspireMD."

"I am very pleased to join InspireMD, as the Company prepares for global commercialization of MGuard™," said Mr. Ratini. "I believe that MGuard™ is an exciting product with the potential of filling a large unmet need and becoming the standard of care for the interventional treatment of Acute MI patients."

Mr. Ratini holds a Master of Computer Sciences from the University of Applied Sciences (HES-SO) in Bienne, Switzerland and a Swiss Federal Diploma of Electronics from Ecole Technique Neuchâtel. In addition, he studied International Marketing at INSEAD in Paris and Management at CQM, Cambridge, USA.

About InspireMD Inc.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is listed on the OTC BB under the ticker symbol "NSPR".

Forward-looking Statements:

This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of ou
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 01, 2015 Research ... of the "Elemental Analysis Market by Type ... OES)), Application (Life Sciences, Food and Beverage Testing, ... 2020" report to their offering. ... of types, technologies, and applications. By type, the ...
(Date:7/7/2015)... FREMONT, Calif. , July 7, 2015 /PRNewswire/ ... and Velos, Inc. have entered into a seven ... cancer research nationally throughout South Korea ... agreement signing was accompanied by a two day joint workshop ... South Korea.  National Cancer Center President Dr. ...
(Date:7/7/2015)... June 30, 2015 ... announced the addition of the "Biomedical ... their offering. This patent landscape ... imaging is a safe, non-invasive, non-ionizing imaging ... represents a great alternative to traditional medical ...
Breaking Medicine Technology:Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 2National Cancer Center of South Korea and Velos Sign Long-Term Velos eResearch Agreement 3Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3
... , , , , CARMIEL, Israel, Dec. 17 Protalix ... of Sandra Lauterbach to Vice President, Sales and Commercial Affairs. ... will be responsible for all commercial activities, including pre-launch and ... agreement between the Company and Pfizer Inc., as well as ...
... , NASHVILLE, Tenn. , Dec. 16 ... cost management services, today commended two new studies highlighting the ... diagnostic imaging tests. , "When used properly, CT imaging ... M.D., chief medical officer of MedSolutions. "However, these new studies ...
Cached Medicine Technology:Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 2Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 3Protalix Names Sandra Lauterbach Vice President of Sales and Commercial Affairs 4MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3
(Date:7/8/2015)... ... July 08, 2015 , ... LaunchPoint, a provider of ... Gold-Level Fit-Friendly Worksite by the American Heart Association for the second year in ... and stay active through its Swellness Program, which promotes, “It’s swell to be ...
(Date:7/8/2015)... ... July 08, 2015 , ... Health & Disability ... on July 29th in Bettendorf, IA. This workshop will be presented to community-based ... members, veterans, and their families. Professionals from both civilian and military organizations are ...
(Date:7/8/2015)... ... 08, 2015 , ... Garden Retreat Spa , located in the heart ... NYC. The attractive masseuses that staff Garden Retreat Spa specialize in offering table showers, ... With plenty of parking, and a location just a few blocks from Penn Station, ...
(Date:7/7/2015)... ... 08, 2015 , ... The National Association of Professional Women (NAPW) ... the Year Circle. She is recognized with this prestigious distinction for leadership in pharmacy. ... 700,000 members and over 200 operating Local Chapters. , “I’m pleased to recognize Alyssa ...
(Date:7/7/2015)... ... July 07, 2015 , ... World Patent Marketing, a ... a medical invention that prevents IV lines from getting entangled. , "The ... be worth $133 billion by 2016," says Scott Cooper, CEO and Creative Director ...
Breaking Medicine News(10 mins):Health News:LaunchPoint Recognized with Second Consecutive American Heart Association Fit-Friendly Worksite Award 2Health News:Health & Disability Advocates to Host Military Sexual Trauma Workshop for Behavioral Health Practitioners and Victim Advocates 2Health News:Garden Retreat Spa Celebrates 8 Years Serving NYC 2Health News:National Association of Professional Women Inducts Dr. Alyssa Greedy, Pharm. D., Pharmacy Manager at Walgreens, Into its VIP Woman of the Year Circle 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 2Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 3Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 4Health News:New Evidence Shows Why Hospital Weekend Effect Is So Dangerous As World Patent Marketing Introduces A New Medical Invention 5
... August 2010 - The authors of a new ... strategies for reducing cocaine self-administration in animals that ... humans. Glutamate is the primary ... implicated in drug addiction. Metabotropic glutamate receptors (mGluRs) ...
... Rheumatology today announced the release of revised classification ... Against Rheumatism) for rheumatoid arthritis, which will allow ... earlier stages of the diseasebefore joint damage occursultimately ... is a chronic disease that causes pain, stiffness, ...
... , MONDAY, Aug. 9 (HealthDay News) -- Many stroke ... patients are never prescribed recommended medications in the first ... found that 25 percent of stroke patients stopped taking ... three months after their stroke. "Providers should spend ...
... national health care organizations are more likely to undergo ... of insurance, according to a study appearing in an ... Society Nephrology (JASN). The results may provide insights ... they go on dialysis. For patients whose kidneys ...
... NY, August 9, 2010Without hands-on access to doctors and hospitals, ... on telemedicine "visits" with physicians and specialists on land, a ... Telemedicine and e-Health , a peer-reviewed journal published by Mary ... free online at www.liebertpub.com/tmj Work on an ...
... After more than a decade of development at the National ... mosquito-borne dengue virus has begun human clinical testing. The vaccine ... and Infectious Diseases (NIAID) and is undergoing clinical study at ... About 2.5 billion people in more than 100 countries ...
Cached Medicine News:Health News:Drugs to treat cocaine abuse? 2Health News:New way of classifying rheumatoid arthritis aimed at identifying the disease earlier 2Health News:New way of classifying rheumatoid arthritis aimed at identifying the disease earlier 3Health News:Many Stroke Patients Stop Taking Meds, Study Shows 2Health News:Many Stroke Patients Stop Taking Meds, Study Shows 3Health News:Many Stroke Patients Stop Taking Meds, Study Shows 4Health News:Not all kidney patients treated equal: Differences in care for patients beginning on dialysis 2Health News:Not all kidney patients treated equal: Differences in care for patients beginning on dialysis 3Health News:Human clinical trial of NIH-developed dengue vaccine begins 2Health News:Human clinical trial of NIH-developed dengue vaccine begins 3
... The Monarc Subfascial Hammock™ is ... female patients suffering from stress urinary ... by supporting the urethra during abdominal ... or laughing. Monarc's outside-to-in transobturator approach ...
... innovative architecture of the Uretex® ... and integrity for tension-free sling ... anchors securely to surrounding tissue ... alternate fixation devices, minimizing risk ...
Meets the demanding requirements of most pelvic floor reconstructive procedures, and is highly resistant to suture pull-through, demonstrating long-term durability, and serves as a structural support...
NephroMax High Pressure Nephrostomy Balloon Catheter allows one-step, atraumatic dilatation of the nephrostomy tract....
Medicine Products: